PNC Financial Services Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,316
| Closed | -$24.5K | – | 4934 |
|
|
2025
Q1 | $24.5K | Sell |
15,316
-452
| -3% | -$723 | ﹤0.01% | 3451 |
|
|
2024
Q4 | $56.8K | Sell |
15,768
-74
| -0.5% | -$266 | ﹤0.01% | 3033 |
|
|
2024
Q3 | $90.3K | Buy |
15,842
+2,905
| +22% | +$16.6K | ﹤0.01% | 2726 |
|
|
2024
Q2 | $59.8K | Buy |
+12,937
| New | +$59.8K | ﹤0.01% | 2935 |
|
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$11.8K | – | 4697 |
|
|
2022
Q4 | $11.8K | Hold |
2,000
| – | – | ﹤0.01% | 3713 |
|
|
2022
Q3 | $18K | Buy |
+2,000
| New | +$18K | ﹤0.01% | 3488 |
|